Dr Angela Minassian

UK Clinical Vaccine Network Conference
Wednesday 12th - Thursday 13th June 2024

Dr Angela Minassian

I lead a clinical malaria vaccine programme at the University of Oxford which involves testing first-time-in-human vaccines against Plasmodium falciparum and P. vivax, incorporating controlled human malaria infection to test vaccine efficacy. Our trials involve capacity-building with partner sites, spanning Phase I-IIb in the UK, Africa and Thailand. Using the malaria human challenge model I also conduct experimental medicine research to explore mechanisms of disease tolerance, and am developing a novel model of relapse for P. vivax. I have led as Chief Investigator and site Principal Investigator on Phase II-III COVID-19 vaccine trials at the Oxford Vaccine Group and Oxford Health NHS Trust.

Top